Status:
RECRUITING
Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial
Lead Sponsor:
Medical University of Vienna
Conditions:
Overactive Bladder Syndrome
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Background: Overactive bladder describes a syndrome characterized by frequent urges to urinate and increased urination with or without nocturia and with or without urinary incontinence. Overactive bla...
Eligibility Criteria
Inclusion
- diagnosis of overactive bladder syndrome or mixed urinary incontinence with predominance of overactive bladder symptoms
Exclusion
- under age 18
- neurogenic overactive bladder
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06546189
Start Date
April 1 2025
End Date
October 1 2027
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090